Rapid discovery of drug target engagement by isothermal shift assay
K. J. Webb, K. A. Ball, S. J. Coleman, J. Jacobsen, M. Stowell, W. M. Old
Abstract
Identifying protein targets directly bound by drug molecules within living systems remains challenging. Here we present the isothermal shift assay, iTSA, for rapid identification of drug targets. Compared with thermal proteome profiling, a prevailing method for target engagement, iTSA offers a simplified workflow, 4-fold higher throughput, and multiplexed experimental designs with higher replication. We demonstrate application of iTSA to identify targets for several kinase inhibitors in lysates and living cells.
02 /Specification & Classification
Click any tag to browse matching papers- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Direct aliquoting from a single heated well enables fully automated high-throughput thermal proteome profiling
Mirva Pääkkönen, Iris Purma, … Otto Kauko·bioRxiv·Sep 17, 2026
- STREAMLINED PROTEOME-WIDE IDENTIFICATION OF DRUG TARGETS INDICATES ORGAN-SPECIFIC ENGAGEMENT
Tanveer Singh Batth, Marie Locard‐Paulet, … Jesper Velgaard Olsen·Nature CommunicationsPeer-reviewed·Oct 16, 2024
- A Comparison of Quantitative Mass Spectrometric Methods for Drug Target Identification by Thermal Proteome Profiling
A. L. George, F. R. Sidgwick, … M. E. Duenas·bioRxiv·Feb 15, 2023
- Large-scale characterization of drug mechanism of action using proteome-wide thermal shift assays
Jonathan G. Van Vranken, Jiaming Li, … Devin K. Schweppe·bioRxiv·Jan 26, 2024
- Assessing target engagement using proteome-wide solvent shift assays
J. G. Van Vranken, J. Li, … S. P. Gygi·bioRxiv·Jul 22, 2021
- Denaturation-sensitive BRET probes enable intracellular thermal shift measurements across diverse protein targets and biomolecular complexes
J. D. Vasta, A. Michaud, … Matthew B. Robers·bioRxiv·Nov 11, 2026